Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is an integrated beauty and wellness company whose news flow centers on product innovation, device launches, financial performance and global expansion. The company’s public updates highlight its focus on beauty and wellness device systems, nutritional products and anti-aging brands sold through a dynamic affiliate opportunity platform in nearly 50 markets worldwide.
News about Nu Skin often includes announcements of quarterly and full-year financial results, where management discusses revenue, earnings per share, regional performance and non-GAAP metrics such as constant-currency revenue change and adjusted EPS. These releases are frequently accompanied by conference call and webcast details, giving context on operating trends, segment results for the Nu Skin and Rhyz businesses, and guidance ranges.
Another key category of NUS news involves product and technology developments. Recent communications have featured the introduction of Prysm iO, an AI-powered intelligent nutritional wellness platform that measures carotenoid levels through a non-invasive finger scan and connects with Prysm-certified supplements. Nu Skin also issues updates about its portfolio of beauty and wellness device systems and recognition from third parties, such as rankings from Euromonitor International Ltd. for at-home beauty and wellness device systems.
Investors and followers of NUS can also expect news on strategic initiatives, including pre-market and launch activities in emerging markets like India, and commentary on regional trends such as growth in Latin America. Conference participation, moderated fireside chats and strategy discussions at industry events are additional sources of information on the company’s direction. Bookmark this page to monitor Nu Skin’s earnings releases, device and product announcements, geographic expansion updates and other material developments reflected in its news coverage.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Nu Skin Enterprises (NYSE: NUS) announced the resignation of CFO Mark Lawrence, effective March 31, 2023, to pursue other opportunities. Lawrence will continue as a senior advisor until April 2023 to ensure a smooth transition. The board has appointed James D. Thomas, previously the chief accounting officer, as interim CFO while searching for a permanent replacement. The company reaffirmed its first-quarter and annual guidance for 2023, initially provided on February 15, 2023. Nu Skin will release its Q1 results on May 3, 2023, followed by a conference call with investors.
Nu Skin Enterprises, Inc. (NYSE: NUS) reported Q4 2022 revenue of $522.3 million, down 22% year-over-year, impacted by foreign exchange (FX) losses of $51 million. EPS for the quarter was $1.15, improving from a loss of $(0.18) in Q4 2021. For FY 2022, revenue totaled $2.23 billion, down 17%. Looking ahead, Q1 2023 revenue is projected between $450 to $490 million, a decline of 26% to 19%. Annual revenue guidance for 2023 ranges from $2.03 billion to $2.18 billion. The company anticipates ongoing macroeconomic challenges but remains optimistic about its long-term strategy and growth prospects.
Nu Skin Enterprises (NYSE: NUS) announced a quarterly cash dividend increase to $0.39 per share, payable on March 8, 2023, to shareholders recorded by February 27, 2023. This increase marks the 22nd consecutive year of dividend growth, showcasing the company's commitment to returning value to shareholders. Chief Financial Officer Mark Lawrence emphasized the company's strong financial position and its confidence in its long-term direction.
Nu Skin Enterprises, Inc. (NYSE: NUS) announced it has provided 800 million meals to malnourished children globally through its Nourish the Children initiative since 2002. The initiative enables purchases of VitaMeal, a nutrient-rich food, which is then donated to those in need via third-party charities. The success of this program, highlighted by the company’s executive chairman Steven J. Lund, reflects its significant social impact. Nu Skin continues its commitment to address childhood hunger while promoting its health and wellness products.
Nu Skin Enterprises, Inc. (NYSE: NUS) will announce its fourth quarter and full year 2022 financial results on February 15, 2023, after market closure. A conference call with management for investors will follow at 5 p.m. ET on the same day, discussing recent results and future business initiatives. The recorded webcast of this call will be accessible through the company's investor relations page until March 1, 2023.
Nu Skin Enterprises (NYSE: NUS) announced its involvement in the 76th Annual Scientific Meeting of the Society of Cosmetic Chemists in Los Angeles on December 12, 2022. The event is a key gathering for cosmetic science, featuring over 1,000 attendees. Nu Skin scientists are presenting research on a proprietary blend of green tea and alpha-tocopherol for cellulite visibility, while Vice President Dr. Helen Knaggs moderates a panel on beauty trends. Additionally, Paul Cox, Ph.D., will present a keynote on ethnobotanical drug candidates for neurodegenerative diseases.